首页> 外国专利> Process for obtaining a fibrinolytic enzyme from the microalga Chlorella vulgaris

Process for obtaining a fibrinolytic enzyme from the microalga Chlorella vulgaris

机译:从微藻小球藻中获得纤溶酶的方法

摘要

Process for obtaining a fibrinolytic enzyme from the microalga Chlorella vulgaris. Thrombosis and a disease characterized by the appearance of a blood clot, the thrombus in a blood vessel system, which determines the partial or total obstruction and prevents the local circulation. It is estimated that there are 50 cases of thrombosis every 100, 000 inhabitants.The treatment of thrombosis is done in a hospital environment, with the application of anticoagulants intravenously at high doses, to reduce blood viscosity, dissolve the clot, prevent the occurrence of pulmonary embolism and to avoid the formation of a new thrombus. The commercial thrombolytic agents are expensive and have the main disadvantage ocorru00eaencia of internal bleeding.This occurs, therefore, do not have a specific action in the clot, but general in blood system. In this sense, it is important not only to reduce the cost of production of enzymes that act on fibrinolu00edticas clots, but also develop a local application of enzyme therapy.The present invention relates the process of obtaining an enzyme with activity fibrinolu00edtu00edca and fibrinogenolu00edtica for pharmacological use using the micro organism fotossintetizante, Chlorella vulgaris.
机译:从微藻小球藻获得纤溶酶的方法。血栓形成和以血凝块(血管系统中的血栓)出现为特征的疾病,它决定了部分或全部阻塞并阻止了局部循环。据估计,每100,000名居民中有50例血栓形成。在医院环境中进行血栓形成的治疗,并通过大剂量静脉内应用抗凝剂以降低血液粘度,溶解血凝块,防止血栓形成的发生。避免肺栓塞和形成新的血栓。商业溶栓剂价格昂贵,并且具有内部出血的主要缺点,因此发生这种情况在凝块中没有特定作用,但在血液系统中普遍存在。从这个意义上讲,重要的是不仅降低产生作用于纤维蛋白醇的凝块的酶的成本,而且开发酶治疗的局部应用。本发明涉及获得具有活性的纤维蛋白醇的酶的方法。药草中使用的微生物fotossintetizante,可用于药理学上。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号